Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Tong

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|May 1, 1984
Intensely potent morpholinyl anthracyclinesE M Acton, G L Tong, C W Mosher, et al.
Journal of Pharmaceutical Sciences|February 1, 1973
Structural requirements for centrally acting drugs. IE J Lien, G L Tong, J T Chou, et al.
Journal of Medicinal Chemistry|August 1, 1979
Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicityG L Tong, H Y Wu, T H Smith, et al.
Journal of Pharmaceutical Sciences|July 1, 1971
CNS activities of lactam derivativesC Elison, E J Lien, A P Zinger, et al.
Journal of Medicinal Chemistry|July 1, 1986
New cyanomorpholinyl byproduct of doxorubicin reductive alkylationE M Acton, G L Tong, D L Taylor, et al.
Journal of Medicinal Chemistry|August 1, 1979
7-(Aminoethyl) ether and thioether of daunomycinoneE M Acton, G L Tong, C W Mosher, et al.
Journal of Medicinal Chemistry|October 1, 1986
N-(cyanomethyl)- and N-(2-methoxy-1-cyanoethyl)anthracyclines and related carboxyl derivativesE M Acton, G L Tong, D L Taylor, et al.
Journal of Medicinal Chemistry|October 1, 1986
N-(2-hydroxyethyl)doxorubicin from hydrolysis of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicinE M Acton, G L Tong, T H Smith, et al.
Physical Review Letters|October 15, 2008
Anomalous line shape of the cross section for e{+}e{-}--> hadrons in the center-of-mass energy region between 3.650 and 3.872 GeVM Ablikim, J Z Bai, Y Ban, et al.
Physical Review Letters|February 7, 2007
Measurements of the continuum R(uds) and R values in e(+)e(-) annihilation in the energy region between 3.650 and 3.872 GeVM Ablikim, J Z Bai, Y Ban, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|May 1, 1984
Intensely potent morpholinyl anthracyclinesE M Acton, G L Tong, C W Mosher, et al.
Journal of Pharmaceutical Sciences|February 1, 1973
Structural requirements for centrally acting drugs. IE J Lien, G L Tong, J T Chou, et al.
Journal of Medicinal Chemistry|August 1, 1979
Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicityG L Tong, H Y Wu, T H Smith, et al.
Journal of Pharmaceutical Sciences|July 1, 1971
CNS activities of lactam derivativesC Elison, E J Lien, A P Zinger, et al.
Journal of Medicinal Chemistry|July 1, 1986
New cyanomorpholinyl byproduct of doxorubicin reductive alkylationE M Acton, G L Tong, D L Taylor, et al.
Journal of Medicinal Chemistry|August 1, 1979
7-(Aminoethyl) ether and thioether of daunomycinoneE M Acton, G L Tong, C W Mosher, et al.
Journal of Medicinal Chemistry|October 1, 1986
N-(cyanomethyl)- and N-(2-methoxy-1-cyanoethyl)anthracyclines and related carboxyl derivativesE M Acton, G L Tong, D L Taylor, et al.
Journal of Medicinal Chemistry|October 1, 1986
N-(2-hydroxyethyl)doxorubicin from hydrolysis of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicinE M Acton, G L Tong, T H Smith, et al.
Physical Review Letters|October 15, 2008
Anomalous line shape of the cross section for e{+}e{-}--> hadrons in the center-of-mass energy region between 3.650 and 3.872 GeVM Ablikim, J Z Bai, Y Ban, et al.
Physical Review Letters|February 7, 2007
Measurements of the continuum R(uds) and R values in e(+)e(-) annihilation in the energy region between 3.650 and 3.872 GeVM Ablikim, J Z Bai, Y Ban, et al.
Pageof 4